Quitting smoking during pregnancy reduces a mother's chances of giving birth to a baby with problem behavior.
Quitting smoking during pregnancy reduces a mother's chances of giving birth to a baby with problem behavior, according to a study published in the April issue of the Journal of Epidemiology and Community Health.
Kate E. Pickett, PhD, of the University of York in the United Kingdom, and colleagues analyzed data on over 18,000 infants whose mothers were classified as pregnancy nonsmokers, quitters, and light or heavy smokers. Heavy smoking was classified as at least 10 cigarettes a day. The infants were assessed in terms of temperament, receptivity to novelty, and regularity.
The lowest scores for easy temperament were found among babies whose mothers were heavy smokers, and babies of mothers who quit during pregnancy scored the highest, the investigators found. Smoking during pregnancy was also associated with low positive mood, while quitting during pregnancy was associated with lower risk of distress to novelty and irregularity.
Pickett KE, Wood C, Adamson J, et al. Meaningful differences in maternal smoking behaviour during pregnancy: implications for infant behavioural vulnerability. J Epidemiol Community Health. 2008;62:318-324. doi:10.1136/jech.2006.058768.
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More